Immutep (NASDAQ:IMMP) Stock Price Passes Below Fifty Day Moving Average – Here’s What Happened

Immutep Limited (NASDAQ:IMMP) shares crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $2.28 and traded as low as $1.91. Immutep shares last traded at $1.95, with a volume of 48,963 shares.

Analyst Ratings Changes

Separately, Robert W. Baird cut their price objective on Immutep from $7.00 to $6.00 and set an “outperform” rating on the stock in a research note on Thursday, June 27th.

Immutep Stock Performance

The business’s 50 day moving average is $2.28 and its two-hundred day moving average is $2.39.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. XTX Topco Ltd acquired a new stake in Immutep during the second quarter worth approximately $26,000. BNP Paribas Financial Markets lifted its position in shares of Immutep by 15.4% during the 1st quarter. BNP Paribas Financial Markets now owns 35,300 shares of the biotechnology company’s stock valued at $82,000 after acquiring an additional 4,700 shares during the period. XY Capital Ltd bought a new position in Immutep during the second quarter worth $105,000. Virtu Financial LLC grew its holdings in Immutep by 269.4% in the first quarter. Virtu Financial LLC now owns 45,062 shares of the biotechnology company’s stock worth $105,000 after purchasing an additional 32,864 shares during the period. Finally, Oracle Investment Management Inc. increased its stake in Immutep by 9.4% in the first quarter. Oracle Investment Management Inc. now owns 564,879 shares of the biotechnology company’s stock valued at $1,316,000 after purchasing an additional 48,449 shares in the last quarter. 2.32% of the stock is owned by institutional investors.

Immutep Company Profile

Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. The company is involved in advancing therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system.